Bringing the fundamentals into focus…
Back to Avalo Therapeutics, Inc.
How Avalo Therapeutics, Inc. stacks up
AVTX · against 365 other Healthcare companies of similar size
Growth
0/ 100
Near the bottom of its peers.
Ranked #362 of 366 · scores higher than 0% of peers
Bars: peers in each 10-point band of the growth score52 peers with a growth score of 0–9, including AVTX · Click a bar to see the companies
Why growth scores 0?
Weighted metrics compared with all Healthcare companies.Mainly because of its 3-year revenue growth and revenue growth, which are weaker than most Healthcare peers.
- slower revenue growth over three years: weaker than 100% of peers. 3-year revenue growth: -85.2% vs peer median 5.8%
- slower revenue growth over the last year: weaker than 98% of peers. Revenue growth: -86.6% vs peer median 6.1%
- Earnings per share growth is not reported, so it is left out of the score.
Metric by metric
Position: dot = AVTX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | AVTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 380 reported | -86.6% | 2.7% | 2% | 33% | |
| Earnings per share growthHigher is better · 182 reported | Not reported | 3.8% | — | — | 33% |
| 3-year revenue growthHigher is better · 359 reported | -85.2% | 3.2% | 0% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around AVTX| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 2 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 609M USD | 99 | 91 | |
| 355 | 366M CHF (≈$421M) | 2 | 23 | |
| 360 | 3.4B CNY (≈$482M) | 1 | 22 | |
| 360 | 327M USD | 1 | 11 | |
| 362 | 4.6B CNY (≈$645M) | 0 | 17 | |
| 362 | 389M USD | 0 | 33 | |
| 362 | 530M USD | 0 | 23 | |
| 362 | 454M AUD (≈$299M) | 0 | 7 | |
| 362 | 57.0B INR (≈$684M) | 0 | 40 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score